Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    Bausch + Lomb Corporation (BLCO) Insider Trading Activity

    Healthcare • Medical Instruments & Supplies • 13,000 employees

    Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

    Total Value

    -$2,563,545.44

    Total Shares

    211,582

    Average Trade Value

    -$122,073.59

    Most Active Insider

    Saunders Brent L

    Total Activity: $1,755,025

    Largest Single Transaction

    $1,315,533

    by Saunders Brent L on Dec 23, 2024

    30-Day Activity

    2 Transactions

    Volume: 13,735 shares
    Value: $190,779

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    See Remarks
    Officer
    Apr 24, 2025 3,954 $54,921 62,930 (-6.3%) Payment of Exercise Price
    EVP Chief Legal Officer
    Officer
    Apr 24, 2025 9,781 $135,858 170,576 (-5.7%) Payment of Exercise Price
    President,surgical
    Officer
    Feb 28, 2025 1,110 $17,760 77,380 (-1.4%) Payment of Exercise Price
    President,surgical
    Officer
    Feb 28, 2025 3,029 $48,464 74,351 (-4.1%) Payment of Exercise Price
    President,surgical
    Officer
    Feb 26, 2025 23,423 $0 78,490 (+29.8%) Grant
    EVP of Rd and Cmo
    Officer
    Feb 26, 2025 25,225 $0 119,580 (+21.1%) Grant
    CEO and Chairman of the Board
    Director, Officer
    Feb 26, 2025 168,168 $0 697,156 (+24.1%) Grant
    See Remarks
    Officer
    Feb 26, 2025 23,423 $0 66,884 (+35.0%) Grant
    EVP Chief Legal Officer
    Officer
    Feb 26, 2025 40,540 $0 180,357 (+22.5%) Grant
    Svp, Controller and Cao
    Officer
    Feb 26, 2025 18,581 $0 71,294 (+26.1%) Grant
    EVP and CFO
    Officer
    Feb 26, 2025 59,459 $0 282,295 (+21.1%) Grant
    CEO and Chairman of the Board
    Director, Officer
    Dec 23, 2024 73,782 $1,315,533 553,637 (-13.3%) Payment of Exercise Price
    EVP of Rd and Cmo
    Officer
    Dec 23, 2024 2,751 $49,050 94,355 (-2.9%) Payment of Exercise Price
    EVP Chief Legal Officer
    Officer
    Dec 23, 2024 4,402 $78,488 139,817 (-3.1%) Payment of Exercise Price
    CEO and Chairman of the Board
    Director, Officer
    Dec 23, 2024 24,649 $439,492 528,988 (-4.7%) Payment of Exercise Price
    See Remarks
    Officer
    Dec 23, 2024 2,524 $45,003 43,461 (-5.8%) Payment of Exercise Price
    EVP and CFO
    Officer
    Dec 23, 2024 8,582 $153,017 222,836 (-3.9%) Payment of Exercise Price
    Svp, Controller and Cao
    Officer
    Dec 23, 2024 2,192 $39,083 52,713 (-4.2%) Payment of Exercise Price
    EVP and CFO
    Officer
    Dec 23, 2024 7,249 $129,250 231,418 (-3.1%) Payment of Exercise Price
    Svp, Controller and Cao
    Officer
    Dec 23, 2024 908 $16,190 54,905 (-1.7%) Payment of Exercise Price
    EVP of Rd and Cmo
    Officer
    Dec 23, 2024 2,324 $41,437 97,106 (-2.4%) Payment of Exercise Price